NCT06176989 2026-04-08Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base TumorsNational Institutes of Health Clinical Center (CC)Phase 2 Recruiting40 enrolled
NCT02073994 2026-02-17Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 MutationServierPhase 1 Completed174 enrolled